- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02506218
Optimizing Meal and Snack Timing to Promote Health (S43)
January 9, 2018 updated by: Wayne Campbell, Purdue University
This study will be conducted using standardized techniques to collect blood samples via an acute, randomized, cross-over design.
Subjects will be provided all of their meals the day prior to testing and participate in 3 testing days with a minimum of 1 week break between testing days and a maximum time commitment of 7 weeks.
A trained phlebotomist will place a catheter and collect blood samples from an antecubital vein using sterile techniques.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 39 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
25-39 years old
- BMI between 22-37 kg/m2
- Weight stable (± 4.5 kg) for the previous 3 months
- Not currently (or within the past 6 months) following a vigorous exercise regimen or weight loss program
- No acute illness
- Not smoking
- Not diabetic
- Not pregnant or planning pregnancy in the next 3 months
- Lactose tolerant
- Willing to limit purposeful activity for 48 hours prior to each testing day
- Willing to consume study foods and beverages.
Exclusion Criteria:
- <25 or >39 years old, BMI <22 or >37 kg/m2
- Currently (or within the past 6 months) following a vigorous exercise regimen greater than -3 - 45 minute exercise sessions per week
- Currently following a weight loss program where subject has lost greater than 4.5 kg
- Acute illness
- Smoking
- Diabetic
- Pregnant or planning pregnancy in the next 3 months
- Lactose intolerant
- Unwilling to consume study foods and beverages
- Peri and post-menopausal women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 10 + 20 g protein consumption
10 g breakfast followed by the consumption of a 20g whey protein shake
|
whey isolate
|
|
Active Comparator: 30 g protein breakfast
|
30 g mixed meal breakfast
|
|
Active Comparator: 10 g protein breakfast
|
10 g mixed meal breakfast
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma amino acid concentration
Time Frame: 7 weeks
|
Peak plasma concentration of amino acids
|
7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose concentration
Time Frame: 7 weeks
|
Area under the curve of blood glucose
|
7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
June 24, 2015
First Submitted That Met QC Criteria
July 21, 2015
First Posted (Estimate)
July 23, 2015
Study Record Updates
Last Update Posted (Actual)
January 12, 2018
Last Update Submitted That Met QC Criteria
January 9, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 1501015661
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.